Functional Brands Inc. (NASDAQ:MEHA – Get Free Report) saw a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 2,045,995 shares, a decline of 62.4% from the May 31st total of 5,442,133 shares. Approximately 5.0% of the shares of the stock are sold short. Based on an average trading volume of 33,392,166 shares, the short-interest ratio is presently 0.1 days.
Analyst Ratings Changes
Separately, Weiss Ratings raised shares of Functional Brands from a “sell (e-)” rating to a “sell (e)” rating in a report on Friday, May 1st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.
View Our Latest Analysis on Functional Brands
Institutional Investors Weigh In On Functional Brands
Functional Brands Trading Up 5.7%
NASDAQ MEHA traded up $0.00 during trading hours on Monday, hitting $0.01. 1,369,712 shares of the company were exchanged, compared to its average volume of 24,527,244. Functional Brands has a 52 week low of $0.01 and a 52 week high of $8.00. The company has a quick ratio of 0.64, a current ratio of 1.20 and a debt-to-equity ratio of 0.25. The stock has a 50-day moving average price of $0.07 and a 200 day moving average price of $0.16. The stock has a market cap of $239,360.80 and a PE ratio of -0.02.
Functional Brands (NASDAQ:MEHA – Get Free Report) last announced its earnings results on Friday, May 15th. The company reported ($0.36) EPS for the quarter. The firm had revenue of $1.65 million during the quarter.
Functional Brands Company Profile
Our company operates in the nutraceutical supplement industry. We are a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, mental clarity & focus, sleep, prenatal and urinary. Our end markets focus on end-consumers through different channels that include pharmacies, US wholesalers, international distributors and direct-to-consumers sales. Our products are sold over the counter, and consumers do not need a prescription to purchase our products.
Featured Stories
- Five stocks we like better than Functional Brands
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Functional Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Functional Brands and related companies with MarketBeat.com's FREE daily email newsletter.
